SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 31, 2007
Health Enhancement Products, Inc. |
(Exact Name Of Registrant As Specified In Its Charter) |
Nevada |
(State or Other Jurisdiction of Incorporation) |
000-30415 |
| 87-0699977 |
(Commission File Number) |
| (I.R.S. Employer Identification No.) |
7740 East Evans Rd., Suite A100, Scottsdale, AZ |
| 85260 |
(Address of Principal Executive Offices) |
| (Zip Code) |
(480) 385-3800 |
(Registrant’s Telephone Number, Including Area Code) |
N/A |
(Former Name or Former Address, if Changed Since Last Report) |
Item 8.01: Other Events
On August 31, 2007, the Registrant and its wholly owned subsidiary, HEPI Pharmaceuticals, Inc., issued the press release filed herewith as Exhibit No. 99.1.
Item 9.01: Financial Statements and Exhibits
Exhibit 99.1 August 31, 2007 Press Release of Health Enhancement Products, Inc. and HEPI Pharmaceuticals, Inc.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 31, 2007 | HEALTH ENHANCEMENT PRODUCTS, INC. |
| By /s/Thomas D. Ingolia |
| Thomas D. Ingolia , Chief Executive Officer |